List of Figures:
Figure 1. Research Method Flow Chart 12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 17
Figure 4. Asia Pacific Single Cell Multiomics Market, 2021-2031, $ mn 20
Figure 5. Impact of COVID-19 on Business 25
Figure 6. Primary Drivers and Impact Factors of Asia Pacific Single Cell Multiomics Market 27
Figure 7. Leading Causes of Death in the World, 2000 and 2019, million 30
Figure 8. Total Reported Cases of Lyme Disease by Year in U.S., 1998-2019 31
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 33
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 33
Figure 11. Primary Restraints and Impact Factors of Asia Pacific Single Cell Multiomics Market 35
Figure 12. Investment Opportunity Analysis 39
Figure 13. Porter’s Fiver Forces Analysis of Asia Pacific Single Cell Multiomics Market 42
Figure 14. Breakdown of Asia Pacific Single Cell Multiomics Market by Product Type, 2021-2031, % of Revenue 47
Figure 15. Asia Pacific Addressable Market Cap in 2022-2031 by Product Type, Value ($ mn) and Share (%) 47
Figure 16. Asia Pacific Single Cell Multiomics Market by Product Type: Instruments, 2021-2031, $ mn 48
Figure 17. Asia Pacific Single Cell Multiomics Market by Product Type: Consumables, 2021-2031, $ mn 49
Figure 18. Asia Pacific Single Cell Multiomics Market by Product Type: Software, 2021-2031, $ mn 50
Figure 19. Breakdown of Asia Pacific Single Cell Multiomics Market by Omics Type, 2021-2031, % of Sales Revenue 52
Figure 20. Asia Pacific Addressable Market Cap in 2022-2031 by Omics Type, Value ($ mn) and Share (%) 52
Figure 21. Asia Pacific Single Cell Multiomics Market by Omics Type: Single Cell Genomics (SCG), 2021-2031, $ mn 53
Figure 22. Asia Pacific Single Cell Multiomics Market by Omics Type: Single Cell Transcriptomics (SCT), 2021-2031, $ mn 54
Figure 23. Asia Pacific Single Cell Multiomics Market by Omics Type: Single Cell Proteomics (SCP), 2021-2031, $ mn 55
Figure 24. Asia Pacific Single Cell Multiomics Market by Omics Type: Single Cell Metabolomics (SCM), 2021-2031, $ mn 56
Figure 25. Breakdown of Asia Pacific Single Cell Multiomics Market by Application, 2021-2031, % of Sales Revenue 58
Figure 26. Asia Pacific Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%) 58
Figure 27. Asia Pacific Single Cell Multiomics Market by Application: Clinical Research, 2021-2031, $ mn 59
Figure 28. Asia Pacific Single Cell Multiomics Market by Clinical Research: Oncology, 2021-2031, $ mn 61
Figure 29. Asia Pacific Single Cell Multiomics Market by Clinical Research: Cell Therapy, 2021-2031, $ mn 62
Figure 30. Asia Pacific Single Cell Multiomics Market by Clinical Research: Immunology, 2021-2031, $ mn 63
Figure 31. Asia Pacific Single Cell Multiomics Market by Clinical Research: Neurology, 2021-2031, $ mn 64
Figure 32. Asia Pacific Single Cell Multiomics Market by Clinical Research: Cell Biology, 2021-2031, $ mn 65
Figure 33. Asia Pacific Single Cell Multiomics Market by Clinical Research: Other Types of Clinical Research, 2021-2031, $ mn 66
Figure 34. Asia Pacific Single Cell Multiomics Market by Application: Translation Research, 2021-2031, $ mn 67
Figure 35. Asia Pacific Single Cell Multiomics Market by Application: Synthetic Biology, 2021-2031, $ mn 68
Figure 36. Breakdown of Asia Pacific Single Cell Multiomics Market by Sample Type, 2021-2031, % of Revenue 70
Figure 37. Asia Pacific Addressable Market Cap in 2022-2031 by Sample Type, Value ($ mn) and Share (%) 70
Figure 38. Asia Pacific Single Cell Multiomics Market by Sample Type: Human Samples, 2021-2031, $ mn 71
Figure 39. Asia Pacific Single Cell Multiomics Market by Human Samples: Cancer Tissues, 2021-2031, $ mn 73
Figure 40. Asia Pacific Single Cell Multiomics Market by Human Samples: Stem Cells, 2021-2031, $ mn 74
Figure 41. Asia Pacific Single Cell Multiomics Market by Human Samples: Immune Cells, 2021-2031, $ mn 75
Figure 42. Asia Pacific Single Cell Multiomics Market by Human Samples: Brain Cells, 2021-2031, $ mn 76
Figure 43. Asia Pacific Single Cell Multiomics Market by Human Samples: Other Human Samples, 2021-2031, $ mn 77
Figure 44. Asia Pacific Single Cell Multiomics Market by Sample Type: Animal Samples, 2021-2031, $ mn 78
Figure 45. Asia Pacific Single Cell Multiomics Market by Sample Type: Microbial Samples, 2021-2031, $ mn 79
Figure 46. Breakdown of Asia Pacific Single Cell Multiomics Market by Workflow, 2021-2031, % of Revenue 81
Figure 47. Asia Pacific Addressable Market Cap in 2022-2031 by Workflow, Value ($ mn) and Share (%) 81
Figure 48. Asia Pacific Single Cell Multiomics Market by Workflow: Single-Cell Isolation and Dispensing, 2021-2031, $ mn 82
Figure 49. Asia Pacific Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Fluorescence-Activated Cell Sorting (FACS), 2021-2031, $ mn 84
Figure 50. Asia Pacific Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Microfluidics, 2021-2031, $ mn 85
Figure 51. Asia Pacific Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Magnetic-Activated Cell Sorting (MACS), 2021-2031, $ mn 86
Figure 52. Asia Pacific Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Random Seeding, 2021-2031, $ mn 87
Figure 53. Asia Pacific Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Manual Cell Picking, 2021-2031, $ mn 88
Figure 54. Asia Pacific Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Laser Capture Microdissection, 2021-2031, $ mn 89
Figure 55. Asia Pacific Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Other Technologies of Single-Cell Isolation and Dispensing, 2021-2031, $ mn 90
Figure 56. Asia Pacific Single Cell Multiomics Market by Workflow: Single-Cell Analysis, 2021-2031, $ mn 91
Figure 57. Asia Pacific Single Cell Multiomics Market by Single-Cell Analysis: Polymerase Chain Reaction, 2021-2031, $ mn 93
Figure 58. Asia Pacific Single Cell Multiomics Market by Single-Cell Analysis: Next-Generation Sequencing, 2021-2031, $ mn 94
Figure 59. Asia Pacific Single Cell Multiomics Market by Single-Cell Analysis: Mass Cytometry, 2021-2031, $ mn 95
Figure 60. Asia Pacific Single Cell Multiomics Market by Single-Cell Analysis: Mass Spectrometry, 2021-2031, $ mn 96
Figure 61. Asia Pacific Single Cell Multiomics Market by Single-Cell Analysis: Other Technologies of Single-Cell Analysis, 2021-2031, $ mn 97
Figure 62. Breakdown of Asia Pacific Single Cell Multiomics Market by End User, 2021-2031, % of Revenue 98
Figure 63. Asia Pacific Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 99
Figure 64. Asia Pacific Single Cell Multiomics Market by End User: Research and Academic Laboratories, 2021-2031, $ mn 100
Figure 65. Asia Pacific Single Cell Multiomics Market by End User: Biopharmaceutical and Biotech Companies, 2021-2031, $ mn 101
Figure 66. Asia Pacific Single Cell Multiomics Market by End User: Contract Research Organizations (CROs), 2021-2031, $ mn 102
Figure 67. Asia Pacific Single Cell Multiomics Market by End User: Other End Users, 2021-2031, $ mn 103
Figure 68. Breakdown of APAC Single Cell Multiomics Market by Country, 2021 and 2031, % of Revenue 105
Figure 69. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 106
Figure 70. Single Cell Multiomics Market in Japan, 2021-2031, $ mn 108
Figure 71. Single Cell Multiomics Market in China, 2021-2031, $ mn 110
Figure 72. Single Cell Multiomics Market in Australia, 2021-2031, $ mn 112
Figure 73. Single Cell Multiomics Market in India, 2021-2031, $ mn 114
Figure 74. Single Cell Multiomics Market in South Korea, 2021-2031, $ mn 116
Figure 75. Single Cell Multiomics Market in Rest of APAC, 2021-2031, $ mn 118
Figure 76. Growth Stage of Asia Pacific Single Cell Multiomics Industry over the Forecast Period 120
Asia Pacific single cell multiomics market will grow by 21.8% annually with a total addressable market cap of $ 16,032.0 million over 2022-2031, driven by the rising prevalence of chronic diseases along with the aging population, the widespread product adoption for visualization and analysis, technological advancements along with the rising R&D investment, and the significant growth in the pharmaceutical industry especially personalized medication. Highlighted with 36 tables and 76 figures, this 149-page report “Asia Pacific Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific single cell multiomics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific single cell multiomics market in every aspect of the classification from perspectives of Product Type, Omics Type, Application, Sample Type, Workflow, End User, and Country. Based on Product Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Instruments • Consumables • Software Based on Omics Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Single Cell Genomics (SCG) • Single Cell Transcriptomics (SCT) • Single Cell Proteomics (SCP) • Single Cell Metabolomics (SCM) By Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Clinical Research o Oncology o Cell Therapy o Immunology o Neurology o Cell Biology o Other Types of Clinical Research • Translation Research • Synthetic Biology By Sample Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Human Samples o Cancer Tissues o Stem Cells o Immune Cells o Brain Cells o Other Human Samples • Animal Samples • Microbial Samples By Workflow, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Single-Cell Isolation and Dispensing o Fluorescence-Activated Cell Sorting (FACS) o Microfluidics o Magnetic-Activated Cell Sorting (MACS) o Random Seeding o Manual Cell Picking o Laser Capture Microdissection o Other Technologies of Single-Cell Isolation and Dispensing • Single-Cell Analysis o Polymerase Chain Reaction o Next-Generation Sequencing o Mass Cytometry o Mass Spectrometry o Other Technologies of Single-Cell Analysis By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Research and Academic Laboratories • Biopharmaceutical and Biotech Companies • Contract Research Organizations (CROs) • Other End Users Geographically, the following national/local markets are fully investigated: • Japan • China • South Korea • Australia • India • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Omics Type, Workflow and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: 10x Genomics, Inc. 1CellBio, Inc. Becton, Dickinson and Company Berkeley Lights, Inc. BGI Genomics Co., Ltd. Bio-Rad Laboratories, Inc. Bio-Techne Corporation BioTuring, Inc. Danaher Corporation (Cytiva Life Sciences) Dolomite Bio Fluidigm Corporation Fluxion Biosciences Illimina, Inc Mission Bio, Inc. Namocell, Inc. NanoString Technologies, Inc. Parse Biosciences, Inc. Proteona Qiagen N.V. RareCyte, Inc. Scipio Biosciences SAS Shilps Sciences Takara Bio Inc. (Takara Holdings) Thermo Fisher Scientific Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Read More